Valued at $139.0M at its later-stage round, Sep 2025. Nothing has traded since.
- ·The complete investor list: 11 names
- ·Watch Sparrow Pharmaceuticals: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Sparrow Pharmaceuticals funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Later Stage VC (Series B) | $95.0M | ▮ | ▮ |
| Apr 2024 | Early Stage VC | $10.0M | ▮ | ▮ |
| Dec 2020 | Seed Round | $1.1M | ▮ | ▮ |
| Aug 2018 | Seed Round | $338K | ▮ | ▮ |
Membership and data by Private Market View
Sparrow Pharmaceuticals valuation
Sparrow Pharmaceuticals was valued at $139 million at its later-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Sparrow Pharmaceuticals raised?
Sparrow Pharmaceuticals has raised $146 million across 4 recorded rounds since 2018. The largest was a $95 million Series B in Sep 2025.
Sparrow Pharmaceuticals has filed 5 Form Ds with the SEC since 2019, most recently in Jul 2025 ($61.8 million sold to 17 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Alchemab Therapeutics ($138 million), Imbria Pharmaceuticals ($132 million) and Tahoe ($131 million).
How Sparrow Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Sparrow Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Sparrow Pharmaceuticals
- What is Sparrow Pharmaceuticals worth?
- Sparrow Pharmaceuticals is valued at $139.0M as of Oct 2026. Valued at $139.0M at its later-stage round, Sep 2025. Nothing has traded since.
- How much has Sparrow Pharmaceuticals raised?
- Sparrow Pharmaceuticals has raised $145.8M in total funding across 4 recorded rounds.
- When did Sparrow Pharmaceuticals last raise?
- Sparrow Pharmaceuticals last raised in Sep 2025 (Later Stage VC (Series B)), raising $95.0M.